SEC Form 4 research
| Issuer | Replimune Group, Inc. |
|---|---|
| Tickers | REPL |
| Reporting owners | 52 |
| Officers and directors | 20 |
| Last public filing | 2026-08-20 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-19 | 2026-08-17 | Hill Emily Luisa | S | 9,256 | $14.28 | Not reported |
| 2026-08-12 | 2026-08-10 | Patel Sushil | S | 39,341 | $12.97 | Not reported |
| 2026-08-12 | 2026-08-10 | Hill Emily Luisa | S | 11,448 | $12.97 | Not reported |
| 2026-08-12 | 2026-08-10 | Xynos Konstantinos | S | 11,447 | $12.97 | Not reported |
| 2026-08-12 | 2026-08-10 | Schwendenman Andrew | S | 7,632 | $12.97 | Not reported |
| 2026-08-11 | 2026-08-11 | 667, L.P., BAKER BROS. ADVISORS LP, BAKER FELIX, BAKER JULIAN, Baker Bros. Advisors (GP) LLC, Baker Brothers Life Sciences LP | P | 2,609,946 | $12.06 | Not reported |
| 2026-08-11 | 2026-08-11 | 667, L.P., BAKER BROS. ADVISORS LP, BAKER FELIX, BAKER JULIAN, Baker Bros. Advisors (GP) LLC, Baker Brothers Life Sciences LP | P | 126,394 | $12.06 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.